Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bifidobacterium pseudolongum reduces triglycerides by modulating gut microbiota in mice fed high-fat food

24 Jan 2020

Abstract excerpt

Obesity has become a growing concern around the world. The purpose of this study was to investigate the potential benefit of Bifidobacterium pseudolongum (B. pseudolongum) on obesity, gut microbiota, and its physiological mechanism. The obese mice model was established with a high-fat diet (HFD), and the treatment were used the strain B. pseudolongum. We investigated the changes in fat content, plasma metabolites...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health
Share to Probiotics and Fermented Foods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31987886
DOI: 10.1016/j.jsbmb.2020.105602

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bifidobacterium pseudolongum reduces triglycerides by modulating gut microbiota in mice fed high-fat foodPMID 31987886Read ↗

The human-derived novel gut commensal Luoshenia tenuis regulates body weight and food intake in miceSemantic proximity Read ↗

Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the ResearchSemantic proximity Read ↗

Bifidobacterium animalis subsp. lactis BB-12 Has Effect Against Obesity by Regulating Gut Microbiota in Two Phases in Human Microbiota-Associated RatsSemantic proximity Read ↗

Positive Interventional Effect of Engineered Butyrate-Producing Bacteria on Metabolic Disorders and Intestinal Flora Disruption in Obese MiceSemantic proximity Read ↗

Bifidobacteria attenuate the development of metabolic disorders, with inter- and intra-species differencesSemantic proximity Read ↗

Direct and Indirect Evidence of Effects of Bacteroides spp. on Obesity and InflammationSemantic proximity Read ↗

Traditional Chinese Medicine Formula Kang Shuai Lao Pian Improves Obesity, Gut Dysbiosis, and Fecal Metabolic Disorders in High-Fat Diet-Fed MiceSemantic proximity Read ↗

Machine learning prediction of obesity-associated gut microbiota: identifying Bifidobacterium pseudocatenulatum as a potential therapeutic targetSemantic proximity Read ↗

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axisSemantic proximity Read ↗

The Role of Green Tea on the Regulation of Gut Microbes and Prevention of High-Fat Diet-Induced Metabolic Syndrome in MiceSemantic proximity Read ↗

Limosilactobacillus reuteri BIO7251 administration improves metabolic phenotype in obese mice fed a high fat diet: an inter-organ crosstalk between gut, adipose tissue and nervous system.Semantic proximity Read ↗

Improvement of Metabolic Syndrome in High-Fat Diet-Induced Mice by Yeast β-Glucan Is Linked to Inhibited Proliferation of Lactobacillus and Lactococcus in Gut MicrobiotaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.